Details werden geladen...
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9 - The Economic Times
India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. This cap, effective from November 9, applies to all listed drugs, including Atezolizumab and Bevacizumab. Manufacturers must adjust prices if they exceed the newly calculated maximum retail price. Compliance will be monitored by state drug controllers and hospitals, which play a significant role in drug supply.
Ähnliche Seiten
Centre caps trade margins on 137 cancer drugs, prices likely to fall by up to 70% | Mint
https://www.livemint.com/industry/centre-caps-trade-margins-on-137-cancer-drugs-prices-likely-fall-by-up-to-70-11792248570646.html
Govt caps trade margins on 137 anti-cancer drugs at 30%; revised prices from November 9 - The Tribune
https://www.tribuneindia.com/news/india/nppa-caps-trade-margins-at-30-for-137-anti-cancer-drugs-revised-prices-from-november-9/
Prices of 137 cancer drugs to fall by up to 70% from November 9 | India News - The Times of India
https://timesofindia.indiatimes.com/india/prices-of-137-cancer-drugs-to-fall-by-up-to-70-from-november-9/articleshow/135020339.cms
Modi government takes major decision, caps trade margins on 137 anti-cancer drugs at 30 percent
https://www.india.com/news/india/modi-government-takes-major-decision-caps-trade-margins-on-137-anti-cancer-drugs-at-30-percent-8536958/Centre plans 30% trade-margin cap on non-scheduled cancer drugs | Mint
https://www.livemint.com/industry/centre-plans-30-trade-margin-cap-on-non-scheduled-cancer-drugs-11791462383407.html